These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1813612)

  • 1. Anxiety, depression, and substance use disorders: diagnosis, treatment, and prescribing practices.
    Landry MJ; Smith DE; Steinberg JR
    J Psychoactive Drugs; 1991; 23(4):397-416. PubMed ID: 1813612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety and substance use disorders: the treatment of high-risk patients.
    Landry MJ; Smith DE; McDuff DR; Baughman OL
    J Am Board Fam Pract; 1991; 4(6):447-56. PubMed ID: 1767697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do general practitioners in Thailand diagnose and treat patients presenting with anxiety and depression?
    Lotrakul M; Saipanish R
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):37-42. PubMed ID: 19154210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benzodiazepines in the treatment of anxiety. The risks and alternatives].
    Trucco M
    Rev Med Chil; 1990 Nov; 118(11):1262-70. PubMed ID: 1983806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of mental disorders and psychoactive substance use in metropolitan 17-year old youth population].
    Modrzejewska R; Bomba J
    Psychiatr Pol; 2010; 44(4):579-92. PubMed ID: 20919508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for the patient with treatment-resistant anxiety.
    Coplan JD; Tiffon L; Gorman JM
    J Clin Psychiatry; 1993 May; 54 Suppl():69-74. PubMed ID: 8509358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.
    Enns MW; Swenson JR; McIntyre RS; Swinson RP; Kennedy SH;
    Can J Psychiatry; 2001 Jun; 46 Suppl 1():77S-90S. PubMed ID: 11441774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of depression: prescribing practices of primary care physicians and psychiatrists.
    Olfson M; Klerman GL
    J Fam Pract; 1992 Dec; 35(6):627-35. PubMed ID: 1360490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse in older adults. An overview.
    Widlitz M; Marin DB
    Geriatrics; 2002 Dec; 57(12):29-34; quiz 37. PubMed ID: 12494731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing and use of benzodiazepines: an epidemiologic perspective.
    Balter MB; Uhlenhuth EH
    J Psychoactive Drugs; 1992; 24(1):63-4. PubMed ID: 1352348
    [No Abstract]   [Full Text] [Related]  

  • 12. Anxiety and substance use disorders: a primer for primary care physicians.
    Landry MJ; Smith DE; McDuff D; Baughman OL
    J Am Board Fam Pract; 1991; 4(1):47-53. PubMed ID: 1996512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anxiety and depression--a common mixture].
    Bjelland I; Dahl AA
    Tidsskr Nor Laegeforen; 1999 Sep; 119(22):3277-80. PubMed ID: 10533410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of anxiety and depression in HIV-infected patients.
    Cabaj RP
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):11-6. PubMed ID: 11363692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment.
    Anthenelli RM; Schuckit MA
    J Addict Dis; 1993; 12(3):73-87. PubMed ID: 8251547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comorbidity in organic depressive disorders in patients Specialist Hospital Dr. J. Babinski in Cracow in the years 2008-2010].
    Noga M; Gruszczyński W
    Pol Merkur Lekarski; 2013 Jul; 35(205):43-6. PubMed ID: 23984605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential diagnosis of anxiety. Psychiatric and medical disorders.
    Cameron OG
    Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social anxiety disorder: comorbidity and its implications.
    Lydiard RB
    J Clin Psychiatry; 2001; 62 Suppl 1():17-23; discussion 24. PubMed ID: 11206030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.